SL Science Holding Limited (SLBT)
NASDAQ
$1.57+$0.0100 (+0.64%) on the dayAs of the close; data may be delayed.
SLBT price, last 12 months
Key stats
- Previous close
- $1.56
- Open
- $1.64
- Day range
- $1.42 – $1.64
- 52-week range
- $1.42 – $14.50
- Volume
- 282K
- Avg volume (20 days)
- 97.2K
- Market cap
- $880.4M
Performance
1W−8.7%
1M−39.6%
3M−58.1%
6M—
YTD—
1Y—
Technicals and fundamentals
About SL Science Holding Limited
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
- Listed on
- NASDAQ
- Market cap
- $880.4M